A new international clinical trial has found that people living with major depression can reliably use a noninvasive brain stimulation system at home. Published in JAMA Network Open, the study shows that a relatively complex remote treatment protocol can be delivered safely and feasibly across several countries, while also underscoring the need to better understand what drives symptom improvement in depression trials.